Evidence map›Paper›PMID 29713909›Full record

Trial reportNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2018

Effects of Rifaximin on Central Responses to Social Stress-a Pilot Experiment.

Huiying Wang, Christoph Braun, Paul Enck

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02793193 (Effect of Probiotics on Central Nervous System Functions in Humans), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02793193 phase2 / phase3completednot on this map

Effect of Probiotics on Central Nervous System Functions in Humans

TypeinterventionalSponsorUniversity Hospital TuebingenRan2016 to 2018Enrolled54ConditionsSocial StressArmsProbiotic, Placebo for antibiotic, Antibiotic, Placebo for probiotic
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Stressor-Specific Microbiota Intervention.Frontiers in nutrition · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 3 countries.

Huiying WangDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Osianderstr. 5, 72076, Tübingen, Germany.
Christoph BraunMagnetoencephalography Centre, University Hospital Tübingen, Otfried-Müller-Str 47, 72076, Tübingen, Germany.
Paul EnckDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Osianderstr. 5, 72076, Tübingen, Germany. paul.enck@uni-tuebingen.de.
University of Tübingen · DE

Funding

EU 7th Framework Programme 607652
6 · The paper itself

Abstract

Probiotics that promote the gut microbiota have been reported to reduce stress responses, and improve memory and mood. Whether and how antibiotics that eliminate or inhibit pathogenic and commensal gut bacteria also affect central nervous system functions in humans is so far unknown. In a double-blinded randomized study, 16 healthy volunteers (27.00 ± 1.60 years; 9 males) received either rifaximin (600 mg/day) (a poorly absorbable antibiotic) or placebo for 7 days. Before and after the drug intervention, brain activities during rest and during a social stressor inducing feelings of exclusion (Cyberball game) were measured using magnetoencephalography. Social exclusion significantly affected (p < 0.001) mood and increased exclusion perception. Magnetoencephalography showed brain regions with higher activations during exclusion as compared to inclusion, in different frequency bands. Seven days of rifaximin increased prefrontal and right cingulate alpha power during resting state. Low beta power showed an interaction of intervention (rifaximin, placebo) × condition (inclusion, exclusion) during the Cyberball game in the bilateral prefrontal and left anterior cingulate cortex. Only in the rifaximin group, a decrease (p = 0.004) in power was seen comparing exclusion to inclusion; the reduced beta-1 power was negatively correlated with a change in the subjective exclusion perception score. Social stress affecting brain functioning in a specific manner is modulated by rifaximin. Contrary to our hypothesis that antibiotics have advert effects on mood, the antibiotic exhibited stress-reducing effects similar to reported effects of probiotics (supported by NeuroGUT, a EU 7th Framework Programme ITN no. 607652; ClinicalTrials.gov identifier number NCT02793193).

Indexed as

AdultAnti-Bacterial AgentsBrain WavesDouble-Blind MethodExerciseFemaleGames, ExperimentalGastrointestinal AgentsHealthy VolunteersHumansMagnetic Resonance ImagingMagnetoencephalographyMaleRestRifaximinStress, PsychologicalAnti-Bacterial AgentsGastrointestinal AgentsRifaximinAntibioticCyberballGut–brain axisMEGStress

Identifiers

PMID29713909
PMCPMC6095772
OpenAlexW2801539713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.